Li M, Wu L, Si H, Wu Y, Liu Y, Zeng Y
Signal Transduct Target Ther. 2025; 10(1):71.
PMID: 40025039
PMC: 11873319.
DOI: 10.1038/s41392-024-02081-y.
Gu J, Liang J, Tian T, Lin Y
JACS Au. 2025; 5(2):486-520.
PMID: 40017737
PMC: 11862954.
DOI: 10.1021/jacsau.4c01170.
Li M, Wang Q, Zhu S, Sun W, Ren X, Xu Z
Pharmaceuticals (Basel). 2025; 18(2).
PMID: 40006085
PMC: 11859641.
DOI: 10.3390/ph18020272.
Xu M, Zhou Y, Xu Y, Shao A, Han H, Ye J
Adv Sci (Weinh). 2025; 12(9):e2408436.
PMID: 39792775
PMC: 11884525.
DOI: 10.1002/advs.202408436.
Tan L, Xie J, Liao C, Li X, Zhang W, Cai C
J Nanobiotechnology. 2024; 22(1):682.
PMID: 39506721
PMC: 11542373.
DOI: 10.1186/s12951-024-02963-x.
A bioswitchable delivery system for microRNA therapeutics based on a tetrahedral DNA nanostructure.
Li S, Tian T, Zhang T, Lin Y, Cai X
Nat Protoc. 2024; 20(2):336-362.
PMID: 39215132
DOI: 10.1038/s41596-024-01050-7.
Innovative Nanotechnology in Drug Delivery Systems for Advanced Treatment of Posterior Segment Ocular Diseases.
Wu Y, Li X, Fu X, Huang X, Zhang S, Zhao N
Adv Sci (Weinh). 2024; 11(32):e2403399.
PMID: 39031809
PMC: 11348104.
DOI: 10.1002/advs.202403399.
Tetrahedral framework nucleic acids-based delivery of microRNA-155 alleviates intervertebral disc degeneration through targeting Bcl-2/Bax apoptosis pathway.
Li Z, Tang Y, Wang L, Wang K, Huang S, Chen Y
Cell Prolif. 2024; 57(11):e13689.
PMID: 38899529
PMC: 11533059.
DOI: 10.1111/cpr.13689.
Harnessing tetrahedral framework nucleic acids for enhanced delivery of microRNA-149-3p: A new frontier in oral squamous cell carcinoma therapy.
Xu S, Qin X, Liang J, Fu X, Xiao D, Lin Y
Cell Prolif. 2024; 57(8):e13637.
PMID: 38671577
PMC: 11294420.
DOI: 10.1111/cpr.13637.
Tetrahedral framework nucleic acids/hyaluronic acid-methacrylic anhydride hybrid hydrogel with antimicrobial and anti-inflammatory properties for infected wound healing.
Qi C, Sun Q, Xiao D, Zhang M, Gao S, Guo B
Int J Oral Sci. 2024; 16(1):30.
PMID: 38622128
PMC: 11018755.
DOI: 10.1038/s41368-024-00290-3.
Framework Nucleic Acids-Based VEGF Signaling Activating System for Angiogenesis: A Dual Stimulation Strategy.
Ge Y, Wang Q, Yao Y, Xin Q, Sun J, Chen W
Adv Sci (Weinh). 2024; 11(21):e2308701.
PMID: 38460168
PMC: 11151028.
DOI: 10.1002/advs.202308701.
Tetrahedral framework nucleic acids-based delivery of MicroRNA-22 inhibits pathological neovascularization and vaso-obliteration by regulating the Wnt pathway.
Liu X, Xu X, Lai Y, Zhou X, Chen L, Wang Q
Cell Prolif. 2024; 57(7):e13623.
PMID: 38433462
PMC: 11216936.
DOI: 10.1111/cpr.13623.
MicroRNA-29c-tetrahedral framework nucleic acids: Towards osteogenic differentiation of mesenchymal stem cells and bone regeneration in critical-sized calvarial defects.
Sun J, Chen X, Lin Y, Cai X
Cell Prolif. 2024; 57(7):e13624.
PMID: 38414296
PMC: 11216942.
DOI: 10.1111/cpr.13624.
Tetrahedral DNA loaded siCCR2 restrains M1 macrophage polarization to ameliorate pulmonary fibrosis in chemoradiation-induced murine model.
Li C, Feng X, Li S, He X, Luo Z, Cheng X
Mol Ther. 2024; 32(3):766-782.
PMID: 38273656
PMC: 10928155.
DOI: 10.1016/j.ymthe.2024.01.022.
DNA tetrahedral nanostructures for the biomedical application and spatial orientation of biomolecules.
Wang W, Lin M, Wang W, Shen Z, Wu Z
Bioact Mater. 2023; 33:279-310.
PMID: 38076646
PMC: 10701289.
DOI: 10.1016/j.bioactmat.2023.10.025.
Pioglitazone-Loaded Cartilage-Targeted Nanomicelles (Pio@C-HA-DOs) for Osteoarthritis Treatment.
Chen J, Xu W, Dai T, Jiao S, Xue X, Jiang J
Int J Nanomedicine. 2023; 18:5871-5890.
PMID: 37873552
PMC: 10590558.
DOI: 10.2147/IJN.S428938.
Application and prospects of nucleic acid nanomaterials in tumor therapy.
Lu W, Chen T, Xiao D, Qin X, Chen Y, Shi S
RSC Adv. 2023; 13(37):26288-26301.
PMID: 37670995
PMC: 10476027.
DOI: 10.1039/d3ra04081j.
Therapeutic Benefit of Melatonin in Choroidal Neovascularization During Aging Through the Regulation of Senescent Macrophage/Microglia Polarization.
Cui K, Tang X, Hu A, Fan M, Wu P, Lu X
Invest Ophthalmol Vis Sci. 2023; 64(11):19.
PMID: 37578424
PMC: 10431207.
DOI: 10.1167/iovs.64.11.19.
The Current Progress of Tetrahedral DNA Nanostructure for Antibacterial Application and Bone Tissue Regeneration.
Hong S, Jiang W, Ding Q, Lin K, Zhao C, Wang X
Int J Nanomedicine. 2023; 18:3761-3780.
PMID: 37457798
PMC: 10348378.
DOI: 10.2147/IJN.S403882.
MicroRNA-122-functionalized DNA tetrahedron stimulate hepatic differentiation of human mesenchymal stem cells for acute liver failure therapy.
Wei H, Li F, Xue T, Wang H, Ju E, Li M
Bioact Mater. 2023; 28:50-60.
PMID: 37214257
PMC: 10199164.
DOI: 10.1016/j.bioactmat.2023.04.024.